Will the reduced demand from China lead to any changes in AMAT's capital allocation or R&D strategy? | AMAT (Aug 15, 2025) | Candlesense

Will the reduced demand from China lead to any changes in AMAT's capital allocation or R&D strategy?

Fundamental outlook – The earnings release makes it clear that the slowdown in Chinese fab spending is now a material head‑wind for Applied Materials (AMAT). Management flagged “easing spending” after a rapid manufacturing push, which historically drives a re‑allocation of capital away from growth‑oriented projects toward cash preservation. In practice we can expect AMAT to trim discretionary cap‑ex in its “Advanced Packaging” and “Materials Engineering” divisions and to defer or scale‑back expansion of new fabs that were being built to service China‑based customers. At the same time, the company is likely to double‑down on R&D that supports markets less exposed to geopolitical risk – namely EUV‑compatible lithography, automotive‑grade semiconductors, and AI‑centric chips. Recent shareholder letters have already hinted at a “next‑generation portfolio” focus, and the current demand shock should accelerate that shift, with a higher proportion of the $1.5‑$2 bn annual R&D budget earmarked for differentiated process technologies rather than incremental capacity upgrades for China.

Technical and trading implications – The stock slumped 13% on the day of the guide, taking it below the 50‑day EMA (~$115) and the 200‑day SMA (~$124). Momentum indicators are now in oversold territory (RSI ≈ 34), but volume was unusually heavy on the decline, suggesting the sell‑off is driven more by fundamentals than a purely technical unwind. The nearest intraday support sits near $108–$110; a clean break below $108 would open the path to the $95–$100 range and could attract short‑term sellers looking to capitalize on the downside risk. Conversely, if management issues a revised outlook that narrows the China‑impact gap or announces a concrete R&D “pivot” (e.g., a partnership in advanced packaging for non‑China customers), a bounce back to the 50‑day EMA and a test of the $120 resistance could be plausible within the next 2–3 weeks.

Actionable take‑away – In the near term, the risk‑reward profile favours a modest short position or buying put spreads (e.g., $115/$105 strikes) to capture further downside while limiting exposure to a potential bounce. Keep a close watch on any updates from the next earnings call or a strategic “China‑adjustment” briefing – a clear signal that the company is reallocating cap‑ex to higher‑growth, lower‑risk segments could trigger a short‑cover rally and present a buying opportunity near the $115–$120 zone.